37 related articles for article (PubMed ID: 25348311)
1. The use of MYBL2 as a novel candidate biomarker of cervical cancer.
Martin CM; Astbury K; Kehoe L; O'Crowley JB; O'Toole S; O'Leary JJ
Methods Mol Biol; 2015; 1249():241-51. PubMed ID: 25348311
[TBL] [Abstract][Full Text] [Related]
2. MYBL2 (B-MYB) in cervical cancer: putative biomarker.
Astbury K; McEvoy L; Brian H; Spillane C; Sheils O; Martin C; O'Leary JJ
Int J Gynecol Cancer; 2011 Feb; 21(2):206-12. PubMed ID: 21270603
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer.
Brake T; Connor JP; Petereit DG; Lambert PF
Cancer Res; 2003 Dec; 63(23):8173-80. PubMed ID: 14678972
[TBL] [Abstract][Full Text] [Related]
4. High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a.
Samir R; Asplund A; Tot T; Pekar G; Hellberg D
J Low Genit Tract Dis; 2011 Oct; 15(4):280-6. PubMed ID: 21558960
[TBL] [Abstract][Full Text] [Related]
5. Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model.
Tewari KS; Taylor JA; Liao SY; DiSaia PJ; Burger RA; Monk BJ; Hughes CC; Villarreal LP
Gynecol Oncol; 2000 Apr; 77(1):137-48. PubMed ID: 10739703
[TBL] [Abstract][Full Text] [Related]
6. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma.
Le L; Luo J; Wu H; Chen L; Tang X; Fu F
Eur J Histochem; 2021 Mar; 65(2):. PubMed ID: 33782625
[TBL] [Abstract][Full Text] [Related]
8. MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis.
Musa J; Aynaud MM; Mirabeau O; Delattre O; Grünewald TG
Cell Death Dis; 2017 Jun; 8(6):e2895. PubMed ID: 28640249
[TBL] [Abstract][Full Text] [Related]
9. MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia.
Clarke M; Dumon S; Ward C; Jäger R; Freeman S; Dawood B; Sheriff L; Lorvellec M; Kralovics R; Frampton J; García P
Leukemia; 2013 Mar; 27(3):661-70. PubMed ID: 22910183
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of the MYB proto-oncogene like 2 (MYBL2)-encoding gene as a prognostic and predictive biomarker in human cancers.
Xin Z; Li Y; Meng L; Dong L; Ren J; Men J
Math Biosci Eng; 2022 Jan; 19(2):1825-1842. PubMed ID: 35135230
[TBL] [Abstract][Full Text] [Related]
11. MYBL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential.
Bayley R; Ward C; Garcia P
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188407. PubMed ID: 32853735
[TBL] [Abstract][Full Text] [Related]
12. Mybl2 rejuvenates heart explant-derived cells from aged donors after myocardial infarction.
Rafatian G; Kamkar M; Parent S; Michie C; Risha Y; Molgat ASD; Seymour R; Suuronen EJ; Davis DR
Aging Cell; 2020 Jul; 19(7):e13174. PubMed ID: 32558221
[TBL] [Abstract][Full Text] [Related]
13. Association between B-
Jin Y; Qi G; Chen G; Wang C; Fan X
Oncol Lett; 2021 Feb; 21(2):166. PubMed ID: 33552284
[TBL] [Abstract][Full Text] [Related]
14. Characterization and comparison of genomic profiles between primary cancer cell lines and parent atypical meningioma tumors.
Kim E; Kim M; So K; Park YS; Woo CG; Hyun SH
Cancer Cell Int; 2020; 20():345. PubMed ID: 32742192
[TBL] [Abstract][Full Text] [Related]
15. Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer.
Caponio VCA; Troiano G; Adipietro I; Zhurakivska K; Arena C; Mangieri D; Mascitti M; Cirillo N; Lo Muzio L
Br J Cancer; 2020 Oct; 123(8):1302-1314. PubMed ID: 32684626
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.
Xiong YC; Wang J; Cheng Y; Zhang XY; Ye XQ
Mol Cell Biochem; 2020 May; 468(1-2):185-193. PubMed ID: 32200471
[TBL] [Abstract][Full Text] [Related]
17. Over Expressed TKTL1, CIP-2A, and B-MYB Proteins in Uterine Cervix Epithelium Scrapings as Potential Risk Predictive Biomarkers in HR-HPV-Infected LSIL/ASCUS Patients.
Chiarini A; Liu D; Rassu M; Armato U; Eccher C; Dal Prà I
Front Oncol; 2019; 9():213. PubMed ID: 31001477
[TBL] [Abstract][Full Text] [Related]
18. MYBL2 Is Targeted by miR-143-3p and Regulates Breast Cancer Cell Proliferation and Apoptosis.
Chen J; Chen X
Oncol Res; 2018 Jul; 26(6):913-922. PubMed ID: 29268817
[TBL] [Abstract][Full Text] [Related]
19. HPV disease transmission protection and control.
Christensen ND
Microb Cell; 2016 Sep; 3(9):476-490. PubMed ID: 28357382
[TBL] [Abstract][Full Text] [Related]
20. The cell survival pathways of the primordial RNA-DNA complex remain conserved in the extant genomes and may function as proto-oncogenes.
Sinkovics JG
Eur J Microbiol Immunol (Bp); 2015 Mar; 5(1):25-43. PubMed ID: 25883792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
